Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Research data from Hadassah University, Sharett Institute of Oncology update understanding of cancer gene therapy
April 1st, 2008
Researchers detail in 'Function of heparanase in prostate tumorigenesis: potential for therapy,' new data in cancer gene therapy. According to recent research from Jerusalem, Israel, "Heparanase is the predominant enzyme that cleaves heparan sulfate, the main polysaccharide in the extracellular matrix. Whereas the role of heparanase in sustaining the pathology of human cancer is well documented, its association with prostate carcinoma remains uncertain." "Our research was undertaken to elucidate the significance of heparanase in prostate tumorigenesis and bone metastasis. We applied immunohistochemical analysis of tissue microarray, in vitro adhesion and invasion...
Source: Cancer Weekly (2008-04-01)
|
